Nonsense-mediated decay, SMG1, cancer, anti-tumour immunogenicity, neoantigens, frameshift insertions/deletions, patient-derived fragments.
Lung cancer, microbiome, tumour evolution, intratumoural bacteria
Single-cell RNA sequencing, Tumour-infiltrating B cells, B cell subsets, Checkpoint Inhibitor Response, Publicly available tool
Immunopeptidomics, immunogenomics, vaccine design, immunotherapy, public neoantigens, private neoantigens, MHC Class I, hotspots, focal regions, bioinformatics.
Renal Cancer, ccRCC, Tumour Microbiome, Myeloid Inflammation